Breast Cancer Research

official impact factor 5.79

Highly Access Editorial

PARP inhibitors and the treatment of breast cancer: beyond BRCA1/2?

Kristine M Frizzell and W Lee Kraus*

Breast Cancer Research 2009, 11:111 doi:10.1186/bcr2451


See related research by Inbar-Rozensal et al., http://breast-cancer-research.com/content/11/6/R78

No comments have yet been made on this article.

Post a comment